Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Treatment and Research|July 19, 2019
Anticoagulation in the Setting of Primary and Metastatic Brain TumorsCharlene Mantia, Jeffrey I Zwicker
Blood|May 5, 2017
Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparinCharlene Mantia, Erik J Uhlmann, Maneka Puligandla, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolismBrian J Carney, Erik J Uhlmann, Maneka Puligandla, et al.
The Oncologist|March 16, 2022
Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial CarcinomaPraful Ravi, Arvind Ravi, Irbaz B Riaz, et al.
BJUI Compass|February 28, 2022
FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinomaElio Adib, Talal El Zarif, Rohit K Jain, et al.
Clinical Genitourinary Cancer|April 9, 2026
Radiation and Avelumab in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder CancerKent W Mouw, Kee-Young Shin, James Parisi, et al.
JAMA Oncology|May 30, 2020
Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell CarcinomaPraful Ravi, Charlene Mantia, Christopher Su, et al.
Journal for Immunotherapy of Cancer|February 3, 2024
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancerPraful Ravi, Dory Freeman, Jonathan Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2025
Increased ErbB2 signaling is an early adaptation to androgen signaling inhibition and persists in castration resistant prostate cancerJude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2026
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2Emre Yekedüz, Weiwei Bian, Stephanie E Siegmund, et al.
Pageof 2